Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$821M |
| 2 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$568M |
| 3 |
Advanced Micro Devices
AMD
|
+$428M |
| 4 |
XYZ
Block Inc
XYZ
|
+$419M |
| 5 |
VanEck Semiconductor ETF
SMH
|
+$333M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$683M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$488M |
| 3 |
Marvell Technology
MRVL
|
+$420M |
| 4 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$375M |
| 5 |
PayPal
PYPL
|
+$326M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.02% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.27% |
| 4 | Consumer Discretionary | 8.74% |
| 5 | Industrials | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Comfort Systems
FIX
$59.9B
| $1.02M | ﹤0.01% |
8,884
-30,701
| -78% | -$3.57M |
|
702
W.R. Berkley
WRB
$26.6B
| $1.02M | ﹤0.01% |
+21,089
| New | +$1.02M |
|
703
DXP Enterprises
DXPE
$3B
| $1.01M | ﹤0.01% |
+36,799
| New | +$978K |
|
704
Heron Therapeutics
HRTX
$92.9M
| $1.01M | ﹤0.01% |
403,228
+222,347
| +123% | +$716K |
|
705
Vanda Pharmaceuticals
VNDA
$305M
| $996K | ﹤0.01% |
134,792
+32,136
| +31% | +$313K |
|
|
JNPR
706
DELISTED
Juniper Networks
JNPR
| $979K | ﹤0.01% |
30,633
-2,398
| -7% | -$72.6K |
|
|
HOLX
707
DELISTED
Hologic
HOLX
| $972K | ﹤0.01% |
12,991
-1,568
| -11% | -$112K |
|
708
CVB Financial
CVBF
$4B
| $964K | ﹤0.01% |
37,421
-14,017
| -27% | -$382K |
|
709
Columbia Banking Systems
COLB
$8.83B
| $963K | ﹤0.01% |
31,961
+6
| +0% | +$191 |
|
710
Ironwood Pharmaceuticals
IRWD
$713M
| $932K | ﹤0.01% |
75,247
-21,494
| -22% | -$244K |
|
711
Allient
ALNT
$1.91B
| $928K | ﹤0.01% |
+26,652
| New | +$879K |
|
712
Northrop Grumman
NOC
$81B
| $910K | ﹤0.01% |
1,668
+472
| +39% | +$246K |
|
713
Wells Fargo
WFC
$263B
| $906K | ﹤0.01% |
21,949
-4,301
| -16% | -$190K |
|
714
Chubb
CB
$135B
| $897K | ﹤0.01% |
4,064
+2,763
| +212% | +$575K |
|
715
Arista Networks
ANET
$238B
| $883K | ﹤0.01% |
29,096
-11,904
| -29% | -$366K |
|
716
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $875K | ﹤0.01% |
17,564
-1,085
| -6% | -$53.7K |
|
717
NIO
NIO
$11.8B
| $873K | ﹤0.01% |
89,530
+71,677
| +401% | +$826K |
|
718
PNC Financial Services
PNC
$101B
| $869K | ﹤0.01% |
5,504
-1,815
| -25% | -$286K |
|
|
PNT
719
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $867K | ﹤0.01% |
118,906
| – | – |
|
720
iShares MSCI Spain ETF
EWP
$2.16B
| $859K | ﹤0.01% |
35,544
-13,165
| -27% | -$299K |
|
721
Zimmer Biomet
ZBH
$18.3B
| $835K | ﹤0.01% |
6,552
-360
| -5% | -$41.8K |
|
722
Deckers Outdoor
DECK
$13.3B
| $833K | ﹤0.01% |
+12,516
| New | +$757K |
|
723
Fidelity National Information Services
FIS
$21.9B
| $814K | ﹤0.01% |
11,992
-13
| -0.1% | -$924 |
|
724
Pacira BioSciences
PCRX
$1B
| $805K | ﹤0.01% |
20,858
+54
| +0.3% | +$2.63K |
|
|
SNV
725
DELISTED
Synovus
SNV
| $803K | ﹤0.01% |
21,389
+3
| +0% | +$119 |
|
Similar funds
Ken Fisher's Q4 2022 Portfolio in Review
As of Q4 2022, Ken Fisher held 1,228 positions worth $148B, up 11% from $133B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q4 2022 filing shows 150 new, 438 increased, 394 reduced and 203 closed positions. Its largest new stake was Macerich: 4,023,537 shares worth $45.3M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $683M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q4 2022 buy was Macerich: 4,023,537 shares worth $45.3M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2022, an estimated $821M increase.
- Ken Fisher's biggest Q4 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $683M.
- Ken Fisher fully exited Fair Isaac in Q4 2022, selling an estimated $35.3M.
- Ken Fisher's ten largest holdings make up 26% of its $148B portfolio in Q4 2022.
- Ken Fisher opened 150 new positions and closed 203 in Q4 2022.
- Ken Fisher's portfolio value rose 11% quarter-over-quarter to $148B.
Based on Fisher Asset Management's 13F filing for Q4 2022, filed 3 Feb 2023.